Authors
Latest:
Make Drug Disposal as Common as Seat BeltsIncluding medication disposal methods with prescriptions could reduce opioid diversion and childhood poisonings.
Latest:
The Impact of Abuse Deterrent Technologies on Prescription Opioid TrendsThe authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Latest:
FDA Bars Generic Version of OxyContinThe FDA will not approve generic forms of OxyContin that lack abuse-resistant features-and OxyContin's manufacturer will be able to state that the drug has tamper-resistant properties.
Latest:
Counseling Patients with HIV/AIDSIt is prudent for pharmacists to stay current with these therapies and prevention strategies, as they are well-positioned to educate and support patients in their illness.
Latest:
HIV Cure Called 'Major Scientific Priority'Researchers continue pursuit of vaccine that will lead to HIV cure.
Latest:
Cost Implications of Early Treatment Initiation Among Patients With Newly Diagnosed FibromyalgiaInitiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.
Latest:
Lung Cancer: Copayments and Behavior Following Erlotinib Formulary Tier ChangeMoving erlotinib from formulary tier 3 to tier 2 resulted in lower copayments and higher treatment persistence among lung cancer patients.
Latest:
CMS Revisiting Coverage Policies for Aprepitant and AmyvidThe specialty pharmacy community should remain alert in the coming months as the MEDCAC receives public comments and considers the future of Medicare coverage for 2 major therapies. The MEDCAC decision can have far-reaching impact on patient access.
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Specialty Pharmacy Access to Medical Records for Patients: How it Affects CareSpecialty pharmacies dispensing erythropoiesis-stimulating agents can improve outcomes by effectively monitoring patients.
Latest:
New Compounds Protect Against Nervous System Structural Damage from Multiple SclerosisNewly characterized compounds found to block inflammation and nerve cell damage.
Latest:
Take Note: Vitamin B12 Has a Reputation in the Singing CommunityLaryngologists are unsure that vitamin B12 therapy provides any benefit and would not prescribe it.
Latest:
Cost Impact of Switching From Metoprolol to Nebivolol for HypertensionA large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Latest:
The Expanding Role of New Medications in the Treatment of Type 2 Diabetes MellitusWe examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Latest:
Consider Impact of Certain Medications on Brain FunctionPharmacists can identify drugs that cause problems, guide selection, and recommend treatment strategies.
Latest:
Pharmacogenetic Resources: PharmGKB and Clinical Pharmacogenetics Implementation ConsortiumPharmacogenetics is the study of how genes impact drug response, an integral part of personalized medicine.
Latest:
Protein S DeficiencyProtein S deficiency is a type of inherited thrombophilia associated with increased risk of venous thromboembolism.
Latest:
National Comprehensive Cancer Network Guideline Updates From the 15th Annual CongressThe continuing education article reviews some of the updates to the National Comprehensive Cancer Network practice guidelines.
Latest:
Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric HospitalAdherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Latest:
Treatment of Neuropathic PainChronic pain has been defined by the International Association for the Study of Pain as pain that persists beyond the normal tissue healing time of 3 months, and it may be classified into 3 distinct categories: nociceptive, neuropathic, and a mixture of the two.
Latest:
E-Cigarettes and Vaping: Another Cardiovascular Threat in Disguise?Since its introduction to the US market in 2003, questions have risen as to the safety, long-term consequences, and risk of cardiovascular detriments that e-cigarettes pose to users.
Latest:
CDC Makes Recommendations for Preserving Brain HealthFew drugs are available to address cognitive decline, but dietary changes, mental and physical activity, and social engagement can all help.
Latest:
Sweating the Small Stuff: Enforcement Trends Focusing on Day-to-Day Specialty Pharmacy OperationsSpecialty pharmacies should not let the new trend of enforcement on day-to-day operations fly under their radar.
Latest:
FDA Is Evaluating the Prospect of Removing Phenylephrine From OTC ShelvesOral phenylephrine is a common ingredient in OTC products, but its clinical efficacy is questionable. The FDA is considering removing it from the market.
Latest:
Improve Medication Adherence in Patients with HIVPharmacists can motivate patients to stick to their drug regimens to decrease viral load and prevent further transmission.
